Direct Meds vs FuturHealth
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Direct Meds
Best for listed for transparent disclosure — see FDA warning and BBB complaint pattern before consideringStarting at $249/mo
FuturHealth
Best for pending product verificationStarting at $199/mo
Side-by-Side Comparison
| Feature | Direct Meds | FuturHealth |
|---|---|---|
| Overall Score | 5.4/10 | ✓7.1/10 |
| Starting Price | $249/mo | ✓$199/mo |
| Editorial Rating | 2.7 ★ /5 | ✓3.6 ★ /5 |
| Features | ✓5 features | 2 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | 1 warning | ✓None |
Pros & Cons
Direct Meds
Pros
- ✓Both semaglutide and tirzepatide available in injection and sublingual formats
- ✓All-inclusive pricing with medication, consultations, supplies, and 1–2 day temperature-controlled shipping
- ✓LegitScript certification confirmed (verified December 2025)
- ✓Named 503A pharmacy partners: CraftedRx (Warrenton, MO) and ChemistryRx (Folcroft, PA)
Cons
- ✗FDA warning letter September 9, 2025 for misleading marketing of compounded GLP-1s as equivalent to FDA-approved drugs — compliance status post-warning not publicly documented
- ✗Extensive Better Business Bureau complaint pattern (rating 1.12/5 across 226 reviews as of April 2026) documenting a hidden 3-month commitment trap: multiple users report being charged $940+ for a 3-month supply when they believed they were purchasing 1 month. Direct Meds disputes the characterization but the complaint volume is material
- ✗Katalys program name 'Direct Meds GLP-1 Offers Top Funnels' and $280 CPA payout indicate aggressive performance-marketing optimization, which can correlate with conversion-first UX patterns
- ✗Rating discrepancy: Trustpilot 4.6/5 from 7,500+ reviews vs. BBB 1.12/5 from 226 reviews — suggests either review-solicitation bias or genuine unresolved customer experience issues
- ✗Not available in Mississippi, Louisiana, or California
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Incorporated May 2024 — less than 2 years of operational history
- ✗Auto-renewal continues until manual email cancellation; BBB complaints report retention-department friction and hold times exceeding 15 minutes
FuturHealth
Pros
- ✓Katalys-approved program at $180 default CPA — non-trivial commission
- ✓Explicitly positioned around weight loss medication (not a general telehealth catch-all)
Cons
- ✗Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
- ✗Domain not yet verified — futurhealth.com may not be the correct landing page
Our Verdict
FuturHealth edges out Direct Meds with a higher overall score of 7.1/10 and is particularly strong for pending product verification. Direct Meds remains a solid alternative, especially if you're looking for listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.